{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024046","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.836868+00:00","generated_at":"2026-06-01T04:03:44.561744+00:00","sec_items":["1.01","3.03","5.02","5.03","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MyMD appoints Glass as President/CMO, Friscia to board; Chapman departs; preferred shares increased","bullets":["Mitchell Glass, M.D. appointed President & CMO effective June 13, 2024; no additional compensation.","Stephen Friscia appointed to board of directors, nominated by PharmaCyte Biotech per SPA.","Christopher Chapman, M.D. resigned as President, CMO and director effective June 14, 2024; separation includes $125K installments, $25K one-time, COBRA, option acceleration.","Amendment filed to increase authorized Series G Preferred shares from 8,950 to 12,826,273 for in-kind dividends.","Chapman's departure amicable; he will focus on Telomir Pharmaceuticals (TELO)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024046","json":"https://secwatch.observer/filing/0001493152-24-024046.json","markdown":"https://secwatch.observer/filing/0001493152-24-024046.md","text":"https://secwatch.observer/filing/0001493152-24-024046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024046/0001493152-24-024046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024046/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:03:44.561744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c17200735","claim":"Stephen Friscia was appointed as Director at Q/C TECHNOLOGIES, INC..","evidence_excerpt":"On June 13, 2024, Mr. Stephen Friscia was appointed to serve as a member of the Board until his successor has been duly elected and qualified or until his earlier resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024046/0001493152-24-024046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6301eeca6b","claim":"Christopher Chapman resigned as President and Chief Medical Officer at Q/C TECHNOLOGIES, INC..","evidence_excerpt":"the Company and Christopher Chapman, M.D. mutually agreed on the separation of Dr. Chapman from his position as President, Chief Medical Officer and member of the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024046/0001493152-24-024046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"8b690b239c","claim":"Mitchell Glass was appointed as President and Chief Medical Officer at Q/C TECHNOLOGIES, INC..","evidence_excerpt":"On June 13, 2024, the Company appointed Mitchell Glass, M.D., a current member of the Board, to the positions of President and Chief Medical Officer, effective as of June 13, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024046/0001493152-24-024046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}